GlassScriptPhysician profile
Martin Nunes
NPI 1073869996
$1,263.66
in general payments reported to CMS, 2019-2025
10 companies · $214 in 2025
The $214 reported for 2025 was more than what 77% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.05 · 2020: $26.39 · 2021: $31.72 · 2022: $436 · 2023: $316 · 2024: $214 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668 · Consulting Fee: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $668.32 |
| Consulting Fee | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $657.76 | 2022-2025 | |
| Align Technology, INC. | $219.60 | 2022-2025 | Invisalign, Invisalign Go |
| Straumann USA LLC | $136.31 | 2025 | |
| Philips North America LLC | $117.91 | 2019-2022 | |
| Dentsply Sirona INC | $50.46 | 2022 | |
| Biohorizons Implant Systems INC. | $19.47 | 2023 | Biohorizons |
| Henry Schein, INC. | $18.61 | 2021 | |
| Elevate Oral Care | $15.56 | 2022 | |
| Implant Direct Sybron International LLC | $14.87 | 2020 | |
| Colgate Oral Pharmaceuticals, INC. | $13.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Nunes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.